创模生物科技(北京)有限公司

CN / En

NEWS

What are the applications of InnoModels Bio's Luminex platform?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-19 16:11
  • Views:

(Summary description)The applications of the InnoModels BioLuminex platform are mainly focused on pharmaceutical R&D, especially in oncology and tumor immunology preclinical drug evaluation. With its unique technical features and advantages, the platform provides powerful technical support for researchers.

What are the applications of InnoModels Bio's Luminex platform?

(Summary description)The applications of the InnoModels BioLuminex platform are mainly focused on pharmaceutical R&D, especially in oncology and tumor immunology preclinical drug evaluation. With its unique technical features and advantages, the platform provides powerful technical support for researchers.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-19 16:11
  • Views:
Information

The applications of the InnoModels BioLuminex platform are mainly focused on pharmaceutical R&D, especially in oncology and tumor immunology preclinical drug evaluation. With its unique technical features and advantages, the platform provides powerful technical support for researchers. The following are the main applications of the platform:
1. Multiplexed quantitative analysis of cytokines:
The Luminex platform is capable of accurately determining the levels of a wide range of cytokines, including multiple quantitative analyses in cytokine release assays, providing comprehensive data support for evaluating the effectiveness of immunotherapy.
With only 25 μL of serum sample, quantitative testing of up to 50 indicators can be accomplished, greatly improving experimental efficiency.
2. Drug screening and evaluation:
The Luminex platform plays an important role in drug screening and evaluation, providing researchers with precise and multiplexed data on the effects of drugs on cytokines and other immune response-related proteins.
For example, the Luminex Mouse Multifactor Assay Kit was used to quantify the expression of cytokines in serum to aid in the evaluation of the biosafety of novel nanoparticles in a study at Shaw Hospital, Zhejiang University School of Medicine.

 


3. Preclinical evaluation of tumor immunotherapy:
The Luminex platform is particularly well suited for preclinical evaluation of tumor immunotherapies by detecting changes in cytokines and other immune response-associated proteins, providing investigators with important information about drug efficacy and safety.
4. Broad research areas:
In addition to oncology and tumor immunology research, the Luminex platform is also applicable to other research areas, such as pathogenesis research of inflammation, infection, endocrine, digestive system and other diseases, as well as evaluation of drug activity/mechanism of action.
5. High-throughput generic clinical trials:
In the early stage of new drug development, the Luminex platform is combined with organoid/PDC and other in vitro platforms to conduct high-throughput generic clinical efficacy testing to meet the needs of clinical commercial value prediction of new drugs and subsequent development strategy formulation.
In summary, with its unique technical features and wide range of applications, the Luminex platform of InnoModels Biotechnology provides powerful support to researchers in the field of pharmaceutical R&D, and especially plays an important role in preclinical drug evaluation of oncology and tumor immunology.

Keyword:

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
Previous page
1
2
42
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司